Avanir Pharmaceuticals To Present At RBC Capital Markets' 2013 Global Healthcare Conference

    Avanir Pharmaceuticals To Present At RBC Capital Markets' 2013 Global
                            Healthcare Conference

PR Newswire

ALISO VIEJO, Calif., Feb. 14, 2013

ALISO VIEJO, Calif., Feb. 14, 2013 /PRNewswire/ -- Avanir Pharmaceuticals,
Inc. (NASDAQ: AVNR) today announced that company management will present an
overview of the company at the RBC Capital Markets' 2013 Global Healthcare
Conference.

  o Location: Palace Hotel, New York, NY
  o Presentation date: Tuesday February 26, 2013
  o Presentation time: 4:35 p.m. ET

A live webcast and 30-day archive of this presentation will be available at
http://ir.avanir.com.

About Avanir Pharmaceuticals, Inc.

Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on
bringing innovative medicines to patients with central nervous system
disorders of high unmet medical need. As part of our commitment, we have
extensively invested in our pipeline and are dedicated to advancing medicines
that can substantially improve the lives of patients and their loved ones. For
more information about Avanir, please visit www.avanir.com.

AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc.
in the United States and other countries.

^©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

(Logo:  http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

 

Avanir Investor & Media Contact
Ian Clements, PhD
ir@avanir.com
+1 (949) 389-6700

SOURCE Avanir Pharmaceuticals, Inc.

Website: https://www.avanir.com